India announced Tuesday, a partial lift to prevent the export of hydroxychloroquine for the treatment of malaria, which some scientists also consider appropriate to treat the emerging coronavirus, after US President Donald Trump's threats.
India, the huge producer of this drug, in South Asia, banned the export of the drug chlorine, which has been used for decades in the treatment of malaria, in order to meet its national needs first.
In the absence of a cure for the virus that has swept the world, there is an intense debate in the medical community about the appropriateness of asylum for Chloroquine and Hydroxychloroquine to treat people with COFED-19.
Although many experts called for caution in this regard, Trump described the drug as a gift from heaven.
Allow export
The Indian Ministry of Foreign Affairs announced today, Tuesday, that New Delhi would allow the export of hydroxychloroquine and paracetamol, which is banned from exporting last month, in appropriate quantities to all neighboring countries that depend on their production capabilities.
We will also provide these essential medicines to some of the countries affected more than others, ministry spokesman Anurag Srivastava said in a statement.
This comes after a weekend call between Trump and Indian Prime Minister Narendra Modi, during which the US President urged India to allow the export of this drug.
Trump threatens
Unless the medicine is released ... there will be a response, and why not? Trump said Monday.
While some doctors and leaders of countries are calling for the use of hydroxychloroquine against COVID-19, a large part of the scientific community and health authorities in the countries are urging that they wait for accurate scientific confirmation of their ability to treat the virus, warning of the dangers of this to patients, especially after suspicious deaths, especially in France.
Post a Comment